In focus · trending topic

molecular disease screening

9 stories · following the connections

Quotient Limited to Expand Capability of Its MosaiQ™ Next-Generation Transfusion Diagnostics Platform to Include Nucleic Acid Testing

By Nasdaq OMXJan 11, 2016, 12:00 PM UTC